sodium phytate has been researched along with phytic acid in 10 studies
*Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent. [MeSH]
*Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buades, JM; Ferrer, MD; Gómez, M; Maduell, F; Martín, E; Perelló, J; Pérez, MM; Rodríguez, NY; Salcedo, C; Torregrosa, JV | 1 |
| Canals, AZ; Ferrer, MD; Joubert, PH; Perelló, J; Salcedo, C; Sinha, S | 1 |
| Campistol, JM; Canals, AZ; Ferrer, MD; Joubert, PH; Maduell, F; Ojeda, R; Perelló, J; Salcedo, C; Torregrosa, V | 1 |
| Bahr, D; Brandenburg, VM; Canals, AZ; Carroll, KJ; Garg, R; Gold, A; Joubert, PH; Miller, S; Perelló, J; Salcedo, C; Sinha, S; Torregrosa, JV | 1 |
| Bellasi, A; Bover, J; Bushinsky, D; Chertow, GM; Garg, R; Gillotti, K; Gold, A; Ketteler, M; Padgett, C; Perelló, J; Raggi, P; Rodriguez, M; Salcedo, C; Sinha, S | 1 |
| Hedayati, SS | 1 |
| Behets, GJ; Brandenburg, VM; D'Haese, PC; Del Mar Pérez, M; Ferrer, MD; Garg, R; Gold, A; Isern, B; Kaesler, N; Perelló, J; Salcedo, C; Wolf, M | 1 |
| Banon-Maneus, E; Campistol, JM; Canals, AZ; Ferrer, MD; Garg, R; Gold, A; Lazo-Rodriguez, M; Miller, S; Perelló, J; Perez, MM; Salcedo, C | 1 |
| Bellasi, A; Bover, J; Bushinsky, DA; Chertow, GM; Garg, R; Gold, A; Ketteler, M; Perelló, J; Raggi, P; Rodriguez, M; Sinha, S | 1 |
| Chertow, GM; Raggi, P; Sinha, S | 1 |
1 review(s) available for sodium phytate and phytic acid
| Article | Year |
|---|---|
SNF472: mechanism of action and results from clinical trials.
Topics: Humans; Kidney Failure, Chronic; Phytic Acid; Renal Dialysis; Vascular Calcification | 2021 |
5 trial(s) available for sodium phytate and phytic acid
| Article | Year |
|---|---|
First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.
Topics: Adult; Aged; Calcium; Double-Blind Method; Healthy Volunteers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Renal Dialysis; Vascular Calcification | 2018 |
A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.
Topics: Aged; Calcinosis; Cardiomyopathies; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Durapatite; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Placebos; Renal Dialysis | 2019 |
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
Topics: Adult; Aged; Aged, 80 and over; Calciphylaxis; Female; Humans; Male; Middle Aged; Pain; Phytic Acid; Prospective Studies; Quality of Life; Time Factors; Wound Healing | 2019 |
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
Topics: Aged; Aortic Valve; Coronary Artery Disease; Disease Progression; Double-Blind Method; Durapatite; Europe; Female; Heart Valve Diseases; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vascular Calcification | 2020 |
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Double-Blind Method; Female; Humans; Male; Middle Aged; Phytic Acid; Renal Dialysis | 2021 |
4 other study(ies) available for sodium phytate and phytic acid
| Article | Year |
|---|---|
SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.
Topics: Calcium; Creatinine; Dialysis Solutions; Hemodiafiltration; Humans; Phytic Acid; Renal Dialysis; Vascular Calcification | 2018 |
A Novel Treatment for Vascular Calcification in Patients With Dialysis-Dependent Chronic Kidney Disease: Are We There Yet?
Topics: Humans; Phytic Acid; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2020 |
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.
Topics: Animals; Calciphylaxis; Dogs; Humans; Phytic Acid; Rats; Renal Dialysis; Vascular Calcification | 2020 |
A novel assay to measure calcification propensity: from laboratory to humans.
Topics: Animals; Aorta; Biomarkers; Calcinosis; Calciphylaxis; Calcium Phosphates; Clinical Laboratory Techniques; Clinical Trials, Phase II as Topic; Disease Progression; Dose-Response Relationship, Drug; Humans; Linear Models; Myocardium; Phytic Acid; Randomized Controlled Trials as Topic; Rats; Renal Dialysis; Spectrophotometry; Vitamin D | 2020 |